利喜定治疗充血性心力衰竭的疗效观察

目的 :旨在观察利喜定治疗充血型心力衰竭的临床效果。方法 :入选充血型心血衰竭患者28例。先停用其它血管扩张剂 ,利喜定以100～400μg/min静脉点滴 ,病情严重者可持续24h～72h ,连用3d～6d。监测患者治疗前后血压、心率及左室射血分数等指标。结果 :用药后 ,患者临床症状和体征明显改善 ,总有效率89 % ,左室收缩功能亦明显改善 ,收缩压与心率乘积下降。结论 :利喜定是一种副作用小、效果可靠、作用缓和平稳的血管扩张剂 ,对充血型心力衰竭疗效肯定。

Therapeutic Effect of Urapidil on Congestive Heart Failure

AIM:28 patients with congestive heart failure (CHF) were selected in this studyThe therapeutic scheme was as follows:after withdrawal of other vasodilators,urapidil was given in dose of 100～400μg/min intravenous drip;in severe case,the administration continued for 24～72 h;treatment lasted 3～6 daysThe patients'blood pressure,heart rate and LVEF were measured before and after treatmentRESULTS:The patients'clinical manifestations were markedly improved with a total effective rate of 89%LVEF was improved obviously too and the product of systolic pressure and heart rate was decreasedCONCLUSION:Urapidil is a vasodilator with slight side effects,reliable effectiveness and moderate action,and has undoubted therapeutic effect on CHF